130 related articles for article (PubMed ID: 32696551)
1. Therapeutic plasma exchange taper does not decrease exacerbations in immune thrombotic thrombocytopenic purpura patients.
Raval JS; Mazepa MA; Rollins-Raval MA; Kasthuri RS; Park YA
Transfusion; 2020 Aug; 60(8):1676-1680. PubMed ID: 32696551
[TBL] [Abstract][Full Text] [Related]
2. Predictive Value of Schistocytes in Recurrence of Acquired Thrombotic Thrombocytopenic Purpura With Severe ADAMTS13 Deficiency at Discontinuation of Daily Therapeutic Plasma Exchange.
Peedin AR; Park YA; Mazepa MA; Rollins-Raval MA; Brecher ME; Raval JS
Ther Apher Dial; 2018 Dec; 22(6):662-665. PubMed ID: 30178615
[TBL] [Abstract][Full Text] [Related]
3. United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange.
Bandarenko N; Brecher ME
J Clin Apher; 1998; 13(3):133-41. PubMed ID: 9828024
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Korkmaz S; Keklik M; Sivgin S; Yildirim R; Tombak A; Kaya ME; Acik DY; Esen R; Hacioglu SK; Sencan M; Kiki I; Tiftik EN; Kuku I; Okan V; Yilmaz M; Demir C; Sari I; Altuntas F; Unal A; Ilhan O
Transfus Apher Sci; 2013 Jun; 48(3):353-8. PubMed ID: 23602056
[TBL] [Abstract][Full Text] [Related]
5. How we treat thrombotic thrombocytopenic purpura: Results of a Canadian TTP practice survey.
Patriquin CJ; Clark WF; Pavenski K; Arnold DM; Rock G; Foley SR;
J Clin Apher; 2017 Aug; 32(4):246-256. PubMed ID: 27476033
[TBL] [Abstract][Full Text] [Related]
6. In patients with suspected immune TTP, admission source impacts hospital length of stay and time to therapeutic plasma exchange impacts clinical outcomes.
Soares Ferreira Junior A; Pinheiro Maux Lessa M; Boyle SH; Sanborn K; Kuchibhatla M; Onwuemene OA
Thromb Res; 2023 Jul; 227():34-39. PubMed ID: 37210956
[TBL] [Abstract][Full Text] [Related]
7. Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.
Liu C; Kallogjeri D; Dynis M; Grossman BJ
Transfusion; 2013 May; 53(5):1096-107. PubMed ID: 22905833
[TBL] [Abstract][Full Text] [Related]
8. Twice-daily therapeutical plasma exchange-based salvage therapy in severe autoimmune thrombotic thrombocytopenic purpura: the French TMA Reference Center experience.
Soucemarianadin M; Benhamou Y; Delmas Y; Pichereau C; Maury E; Pène F; Halimi JM; Presne C; Thouret JM; Veyradier A; Coppo P
Eur J Haematol; 2016 Aug; 97(2):183-91. PubMed ID: 26608617
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic plasma exchange for the treatment of thrombotic thrombocytopenic purpura: a retrospective multicenter study.
Altuntas F; Aydogdu I; Kabukcu S; Kocyigit I; Cikim K; Sari I; Erkut MA; Eser B; Ozturk A; Kaya E; Cetin M; Keskin A; Unal A
Transfus Apher Sci; 2007 Feb; 36(1):57-67. PubMed ID: 17240195
[TBL] [Abstract][Full Text] [Related]
10. Combination vincristine and plasma exchange as initial therapy in patients with thrombotic thrombocytopenic purpura: one institution's experience and review of the literature.
Ziman A; Mitri M; Klapper E; Pepkowitz SH; Goldfinger D
Transfusion; 2005 Jan; 45(1):41-9. PubMed ID: 15647017
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic plasma exchange-free treatment for first-episode TTP: A systematic review.
Wang J; Cheng F; Niu Y; Yan L; Li J; Tan B; Qin L
Transfus Apher Sci; 2023 Jun; 62(3):103661. PubMed ID: 36878741
[TBL] [Abstract][Full Text] [Related]
12. [Venous thrombo-embolism during immune-mediated thrombotic thrombocytopenic purpura is prevalent in patients with a prolonged treatment with therapeutic plasma exchange].
Benhamou Y; Sauvètre G; Grangé S; Veyradier A; Coppo P
Rev Med Interne; 2020 Dec; 41(12):809-813. PubMed ID: 32727695
[TBL] [Abstract][Full Text] [Related]
13. Absolute immature platelet count dynamics in diagnosing and monitoring the clinical course of thrombotic thrombocytopenic purpura.
Hong H; Xiao W; Stempak LM; Sandhaus LM; Maitta RW
Transfusion; 2015 Apr; 55(4):756-65. PubMed ID: 25370931
[TBL] [Abstract][Full Text] [Related]
14. Taking Empiricism out of Immune Thrombotic Thrombocytopenic Purpura: Current and Future Treatment Strategies.
Mazepa MA; Park YA; Raval JS
Transfus Med Rev; 2019 Oct; 33(4):248-255. PubMed ID: 31645275
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of cryoprecipitate-poor plasma as a replacement fluid for therapeutic plasma exchange in thrombotic thrombocytopenic purpura: a single center retrospective evaluation.
Stefanello B; De Paula EV; Andrade Orsi F; Comenalli Marques JF; Gasparotto Roveri E; Pereira Colella M; Castro Ozelo M; Maria Annichino-Bizzacchi J; Addas-Carvalho M
J Clin Apher; 2014 Dec; 29(6):311-5. PubMed ID: 24890787
[TBL] [Abstract][Full Text] [Related]
16. A 14-Year Experience in the Management of Patients with Acquired Immune Thrombotic Thrombocytopenic Purpura in Northern Israel.
Rinott N; Mashiach T; Horowitz NA; Schliamser L; Sarig G; Keren-Politansky A; Dann EJ
Acta Haematol; 2015; 134(3):170-6. PubMed ID: 25997685
[TBL] [Abstract][Full Text] [Related]
17. Treatment of acquired Thrombotic Thrombocytopenic Purpura in the U.S. remains heterogeneous: Current and future points of clinical equipoise.
Mazepa MA; Raval JS; Brecher ME; Park YA
J Clin Apher; 2018 Jun; 33(3):291-296. PubMed ID: 29150875
[TBL] [Abstract][Full Text] [Related]
18. Do infections provoke exacerbations and relapses of thrombotic thrombocytopenic purpura?
Cserti CM; Landaw S; Uhl L
J Clin Apher; 2007 Feb; 22(1):21-5. PubMed ID: 17285617
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of cefoperazone/sulbactam in critically Ill thrombotic thrombocytopenic purpura patients undergoing therapeutic plasma exchange.
Li H; Gao C; Lin L; Zhang G; Fan S; Hai X
J Clin Pharm Ther; 2022 Aug; 47(8):1232-1239. PubMed ID: 35347732
[TBL] [Abstract][Full Text] [Related]
20. High-dose plasma infusion versus plasma exchange as early treatment of thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome.
Coppo P; Bussel A; Charrier S; Adrie C; Galicier L; Boulanger E; Veyradier A; Leblanc T; Alberti C; Azoulay E; Le Gall JR; Schlemmer B
Medicine (Baltimore); 2003 Jan; 82(1):27-38. PubMed ID: 12544708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
